R E Brand. Show Affiliations »
Abstract
Entities: Disease Species
Mesh： See more » Albumins/administration & dosageAlbumins/economicsBacterial Infections/economicsBacterial Infections/mortalityBacterial Infections/therapyCefotaxime/administration & dosageCombined Modality TherapyCost-Benefit AnalysisHospital MortalityHumansInfusions, IntravenousLiver Cirrhosis/economicsLiver Cirrhosis/mortalityLiver Cirrhosis/therapyPeritonitis/economicsPeritonitis/mortalityPeritonitis/therapyPlasma Substitutes/administration & dosagePlasma Substitutes/economicsProspective Studies
Substances： See more » AlbuminsPlasma SubstitutesCefotaxime
Year: 1999 PMID： 10606292 DOI： 10.1111/j.1572-0241.1999.01662.x
Source DB: PubMed Journal: Am J Gastroenterol ISSN： 0002-9270 Impact factor: 10.864